Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend” or the “Company”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease ...

A new prototype blood test for infectious diseases, designed to be delivered and analyzed at the point of care, has the ...

The infant mortality national rate dropped to about 5.5 infant deaths per 1,000 live births in 2024, according to provisional ...

Here is our list of the 10 best cancer stocks to invest in for long term gains. Summit Therapeutics Inc. (NASDAQ:SMMT) is a ...

The landmark achievement in diabetes research in the country could potentially transform how certain rare forms of the ...

Tovecimig (DLL4 x VEGF-A bispecific antibody) met the primary endpoint in the ongoing randomized Phase 2/3 Study in patients with biliary tract cancer (BTC). Achieved a 17.1% overall response rate ...

The thyroid gland is regulated by the hormone TSH, which is produced by the pituitary gland. An imbalance in the production ...

SOUTH SAN FRANCISCO, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today provided a business update and reported ...

Q3 2025 Earnings Call Transcript May 7, 2025 Bio-Techne Corporation beats earnings expectations. Reported EPS is $0.56, ...

Northwestern Medicine investigators have discovered new intracellular mechanisms that help specialized immune cells adapt and ...

In April 2025, our partner Jazz announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of ...